|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pharmacology, Jichi Medical School, Jichi, Tochigi, Japan
2 Pediatrics, University of Rochester School of Medicine, Rochester, New York, United States
* To whom correspondence should be addressed. E-mail: george_schwartz{at}urmc.rochester.edu.
Endothelin and nitric oxide (NO) modulate ion transport in the kidney. In this study we defined the function of ET receptor subtypes and the NO-guanylate cyclase signaling pathway in mediating the adaptation of the cortical collecting duct (CCD) to metabolic acidosis. CCDs were perfused in vitro and incubated for 3 h at pH 6.8, and bicarbonate transport or cell pH measured before and after acid incubation. Luminal chloride was reversibly removed to isolate H+ and HCO3- secretory fluxes, and to raise the pH of
-intercalated cells. Acid incubation caused reversal of polarity of net HCO3- transport from secretion to absorption, comprised of a 40% increase in H+ secretion and a 75% decrease in HCO3- secretion. The ETB receptor antagonist BQ788, as well as the NO synthase inhibitor, L-NAME, attenuated by 40% the adaptive decrease in HCO3- secretion, but only BQ788 inhibited the adaptive increase in H+ secretion. There was no effect of inactive D-NAME or the ETA receptor antagonist BQ123. Both BQ788 and L-NAME inhibited the acid-induced inactivation (endocytosis) of apical Cl-/HCO3- exchanger. The guanylate cyclase inhibitor LY83583 and cyclic GMP-dependent protein kinase inhibitor KT5823 affected HCO3- transport similarly to L-NAME. These data indicate that signaling via the ETB receptor regulates the adaptation of the CCD to metabolic acidosis, and that the NO-guanylate cyclase component of ETB receptor signaling mediates down-regulation of Cl-/HCO3- exchange and HCO3- secretion.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |